FLT3 and acute myeloid leukemia: Co-treatment of FLT3-ITD-expressing primary AML cells with 1 μM AZD1208 caused a significant (P<0.01) concentration-dependent increase in apoptosis induction by topoisomerase 2 inhibitors (Figure 2A, Supplementary Figure S3A, S3B, left).